OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$7.31+0.37 (+5.33%)
Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –
OptimizeRx operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
OptimizeRx's operating income for the twelve months ending Jun 30, 2026 was $10.93M. For fiscal 2025 it was $11.69M. The highest annual figure on record is $11.69M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.69M | – |
| FY2024 | Dec 31, 2024 | -$13.71M | – |
| FY2023 | Dec 31, 2023 | -$26.40M | – |
| FY2022 | Dec 31, 2022 | -$12.29M | -3503.7% |
| FY2021 | Dec 31, 2021 | $361.10K | – |
| FY2020 | Dec 31, 2020 | -$2.14M | – |
| FY2019 | Dec 31, 2019 | -$3.69M | -2150.5% |
| FY2018 | Dec 31, 2018 | $180.13K | – |
| FY2017 | Dec 31, 2017 | -$2.13M | – |
| FY2016 | Dec 31, 2016 | -$1.58M | – |
| FY2015 | Dec 31, 2015 | -$597.41K | – |
| FY2014 | Dec 31, 2014 | -$1.03M | – |
| FY2013 | Dec 31, 2013 | -$267.54K | – |
| FY2012 | Dec 31, 2012 | -$454.92K | – |
| FY2011 | Dec 31, 2011 | -$1.45M | – |
| FY2010 | Dec 31, 2010 | -$1.85M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$88.00K | -102.7% |
| Q1 FY2026 | Mar 31, 2026 | $396.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $8.57M | +135.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.05M | – |
| Q2 FY2025 | Jun 30, 2025 | $3.21M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.10M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.56M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.75M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.55M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.85M | -880.7% |
| Q1 FY2023 | Mar 31, 2023 | -$7.06M | -18594.4% |
| Q4 FY2022 | Dec 31, 2022 | -$864.35K | -354.1% |
| Q1 FY2022 | Mar 31, 2022 | -$3.76M | – |
| Q4 FY2021 | Dec 31, 2021 | $621.08K | -54.2% |
| Q3 FY2021 | Sep 30, 2021 | $38.19K | – |
| Q2 FY2021 | Jun 30, 2021 | $340.14K | – |
| Q1 FY2021 | Mar 31, 2021 | -$638.31K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.36M | +182.6% |
| Q3 FY2020 | Sep 30, 2020 | -$176.72K | -233.7% |
| Q2 FY2020 | Jun 30, 2020 | -$1.06M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.26M | -1112.3% |
| Q2 FY2019 | Jun 30, 2019 | $480.04K | +75.5% |
| Q1 FY2019 | Mar 31, 2019 | $132.17K | – |
| Q4 FY2018 | Dec 31, 2018 | -$125.45K | – |
| Q3 FY2018 | Sep 30, 2018 | $223.18K | – |
| Q2 FY2018 | Jun 30, 2018 | $273.60K | – |
| Q1 FY2018 | Mar 31, 2018 | -$191.20K | – |
| Q4 FY2017 | Dec 31, 2017 | -$239.31K | – |
| Q3 FY2017 | Sep 30, 2017 | -$629.66K | – |
| Q2 FY2017 | Jun 30, 2017 | -$370.56K | – |
| Q1 FY2017 | Mar 31, 2017 | -$890.44K | – |
| Q4 FY2016 | Dec 31, 2016 | -$367.93K | – |
| Q3 FY2016 | Sep 30, 2016 | -$249.22K | – |
| Q2 FY2016 | Jun 30, 2016 | -$602.52K | – |
| Q1 FY2016 | Mar 31, 2016 | -$361.83K | – |
See a number that looks wrong?